Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Герминогенные опухоли у больных СПИДом
Герминогенные опухоли у больных СПИДом
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Нечушкина И.В. Опухоли гонад и пороки развития у детей. Рос. онкол. журн. 2002; 4: 52–4.
2. Buetow SA. Epidemiology of testicular cancer. Epidemiol Rev 1995; 17: 433–49.
3. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med 1997; 337: 242–53.
4. Кутушева Г.Ф., Урманчеева А.Ф. Опухоли и опухолевидные образования половых органов у девочек. СПб.,2001.
5. Dmitrovsky E, Bosl GJ, Chaganti SK. Clinical and genetic features of human germ cell cancer. Cancer Surv 1990; 9: 369–89.
6. Mostofi FK, Sesterhenn IA, Sobin LH. Histological typing of testis tumours, second edition, Springer. Lion 2004; 3: 540–633.
7. Travis LB, Curtis RE, Storm H, Hall P et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 1997; 89: 1429–39.
8. Mostofi FK, Sesterhenn IA, Sobin LH. Histological typing of testis tumors, second edition. Berlin: Springer, 1998.
9. Looijenga LH, Oosterhuis JW. Pathogenesis of testicular germ cell tumors. Rev Reproduct 1999; 4: 90–100.
10. Gundy S, Baki M, Bodrogi I, Czeizel A. Persistence of chromosomal aberrations in blood lymphocytes of testicular cancer patients. Oncology 1990; 47: 410–4.
11. Pedersen-Bjergaard J, Rowley JD. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 1994; 83: 2780–6.
12. Fossa SD, Horwich A, Russell JM et al. Optimal planning target volume for stage I testicular seminoma: a Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group. J Clin Oncol 1999; 17: 1146–54.
13. Garnick MB, Canellos GP, Richie JP. Treatment and surgical staging of testicular and primary extragonadal germ cell cancer. JAMA 1983; 250: 1733–41.
14. Pedersen-Bjergaard J, Daugaard G, Hansen SW et al. Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours. Lancet 1991; 338: 359–63.
15. Bosl GJ, Dmitrovsky E, Reuter VE et al. Isochromosome of the short arm of chromosome 12: clinically useful markers for male germ cell tumors. J Natl Cancer Inst 1989; 81: 1874–8.
16. Nonomura N, Murosaki N, Kojima Y et al. Secondary acute monocytic leukemia occurring during the treatment of a testicular germ cell tumor. A case report and review of the literature. Urol Int 1997; 58: 239–42.
17. Nichols CR, Roth BJ, Heerema N et al. Hematologic neoplasia associated with primary mediastinal germ-cell tumors. N Engl J Med 1990; 1425–9.
18. Fossa S.D, Langmark F, Aass N et al. Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy. Br J Cancer 1990; 61: 639–43.
19. Krywicki R, Bowen K, Anderson L et al. Mixed-lineage acute myeloid leukemia associated with a suprasellar dysgerminoma. Am J Clin Oncol 1995; 18: 83–6.
20. Ladanyi M, Samaniego F, Reuter VE et al. Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors. J Natl Cancer Ins 1990; 221–7.
21. DeMent SH, Eggleston JC, Spivak JL. Association between mediastinal germ cell tumors and hematological malignancies: report of two cases and review of the literature. Am J Surg Pathol 1985; 9: 23–30.
22. Nichols CR, Hoffman R, Einhorn LH et al. Hematologic malignancies associated with primary mediastinal germ-cell tumors. Ann Intern Med 1985; 102: 603–9.
23. Nichols CR, Roth BJ, Heerema N et al. Hematologic neoplasia associated with primary mediastinal germ-cell tumors. N Engl J Med 1990; 322: 1425–9.
24. Ladanyi M, Samaniego F, Reuter VE et al. Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors. J Natl Cancer Inst 1990; 82: 221–7.
25. Orazi A, Neiman RS, Ulbright TM et al. Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors. Cancer 1993; 71: 3873–81.
26. Woodruff K, Wang N, May W et al. The clonal nature of mediastinal germ cell tumors and acute myelogenous leukemia. A case report and review of the literature. Cancer Genet Cytogenet 1995; 79: 25–31.
27. Orazi A, Neiman RS, Ulbright TM et al. Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors. Cancer 1993; 71: 3873–81.
28. Geurts van Kessel A, Van Drunen E, De Jong B et al. Chromosome 12q heterozygosity is retained in i(12p)-positive testicular germ cell tumor cells. Cancer Genet Cytogenet 1989; 40: 129–34.
29. Irie J, Kawai K, Ueno Y et al. Malignant germ cell tumor of the anterior mediastinum with leukemia-like infiltration. Acta Pathol Jpn 1985; 1561–70.
30. Goedert JJ, Cote TR, Virgo P et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998; 351: 1833–9.
31. Sung M-T, MacLennan GT, Lopez-Beltran A et al. Primary mediastinal seminoma. Am J Surg Pathol 2008; 32: 146–55.
32. Hentrich MU, Black NG, Schmid P et al. Testicular germ cell tumors in patients with human immunodeficiency virus Infection. Cancer 1996; 77: 2109–17.
33. Timmerman JM, Northfelt DW, Small EJ. Malignant germ cell tumors in men infected with the human immunodeficiency virus: natural history and results of therapy. J Clin Oncol 1995; 13: 1391–7.
34. Тюляндин С.А. Лечение диссеминированных герминогенных опухолей у мужчин. Дис. ... докт. мед. наук, 1993.
35. Hentrich MU, Brack NG, Schmid P et al. Testicular germ cell tumors in patients with human immunodeficiency virus infection. Cancer 1996; 77: 109–16.
36. Nichols CR, Loehrer PJ, Einhorn LH et al. Phase III study of cisplatin, etoposide and bleomycin or etoposide, ifosfamide and cisplatin in advanced stage germ cell tumors: An intergroup trial. Proc Am Soc Clin Oncol 1995; 14: 239.
37. Albers P, Weinknecht S, Krege S et al. Prediction of necrosis after chemotherapy of advanced germ cell tumors – results of a prospective multicenter trial of the GTCSG. J Urol 2002; 167: 172.
38. De Santis M, Bokemeyer C, Becherer A et al. Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) for residual postchemotherapy masses in patients with bulky seminoma. J Clin Oncol 2001; 19: 3740–4.
39. Aprikian AG, Herr HW, Bajorin DF et al. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular non-seminomatous germ cell tumors. Cancer 1994; 74: 1329–34.
40. Hartmann JT, Candelaria M, Kuczyk MA et al. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumors. Eur J Cancer 1997; 33: 843–7.
41. Fizazi K, Tjulandin S, Salvioni R et al. Viable malignant cells after primary chemotherapy for disseminated non-seminatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy results from an international study. J Clin Oncol 2001; 19: 2647–57.
2. Buetow SA. Epidemiology of testicular cancer. Epidemiol Rev 1995; 17: 433–49.
3. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med 1997; 337: 242–53.
4. Кутушева Г.Ф., Урманчеева А.Ф. Опухоли и опухолевидные образования половых органов у девочек. СПб.,2001.
5. Dmitrovsky E, Bosl GJ, Chaganti SK. Clinical and genetic features of human germ cell cancer. Cancer Surv 1990; 9: 369–89.
6. Mostofi FK, Sesterhenn IA, Sobin LH. Histological typing of testis tumours, second edition, Springer. Lion 2004; 3: 540–633.
7. Travis LB, Curtis RE, Storm H, Hall P et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 1997; 89: 1429–39.
8. Mostofi FK, Sesterhenn IA, Sobin LH. Histological typing of testis tumors, second edition. Berlin: Springer, 1998.
9. Looijenga LH, Oosterhuis JW. Pathogenesis of testicular germ cell tumors. Rev Reproduct 1999; 4: 90–100.
10. Gundy S, Baki M, Bodrogi I, Czeizel A. Persistence of chromosomal aberrations in blood lymphocytes of testicular cancer patients. Oncology 1990; 47: 410–4.
11. Pedersen-Bjergaard J, Rowley JD. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 1994; 83: 2780–6.
12. Fossa SD, Horwich A, Russell JM et al. Optimal planning target volume for stage I testicular seminoma: a Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group. J Clin Oncol 1999; 17: 1146–54.
13. Garnick MB, Canellos GP, Richie JP. Treatment and surgical staging of testicular and primary extragonadal germ cell cancer. JAMA 1983; 250: 1733–41.
14. Pedersen-Bjergaard J, Daugaard G, Hansen SW et al. Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours. Lancet 1991; 338: 359–63.
15. Bosl GJ, Dmitrovsky E, Reuter VE et al. Isochromosome of the short arm of chromosome 12: clinically useful markers for male germ cell tumors. J Natl Cancer Inst 1989; 81: 1874–8.
16. Nonomura N, Murosaki N, Kojima Y et al. Secondary acute monocytic leukemia occurring during the treatment of a testicular germ cell tumor. A case report and review of the literature. Urol Int 1997; 58: 239–42.
17. Nichols CR, Roth BJ, Heerema N et al. Hematologic neoplasia associated with primary mediastinal germ-cell tumors. N Engl J Med 1990; 1425–9.
18. Fossa S.D, Langmark F, Aass N et al. Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy. Br J Cancer 1990; 61: 639–43.
19. Krywicki R, Bowen K, Anderson L et al. Mixed-lineage acute myeloid leukemia associated with a suprasellar dysgerminoma. Am J Clin Oncol 1995; 18: 83–6.
20. Ladanyi M, Samaniego F, Reuter VE et al. Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors. J Natl Cancer Ins 1990; 221–7.
21. DeMent SH, Eggleston JC, Spivak JL. Association between mediastinal germ cell tumors and hematological malignancies: report of two cases and review of the literature. Am J Surg Pathol 1985; 9: 23–30.
22. Nichols CR, Hoffman R, Einhorn LH et al. Hematologic malignancies associated with primary mediastinal germ-cell tumors. Ann Intern Med 1985; 102: 603–9.
23. Nichols CR, Roth BJ, Heerema N et al. Hematologic neoplasia associated with primary mediastinal germ-cell tumors. N Engl J Med 1990; 322: 1425–9.
24. Ladanyi M, Samaniego F, Reuter VE et al. Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors. J Natl Cancer Inst 1990; 82: 221–7.
25. Orazi A, Neiman RS, Ulbright TM et al. Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors. Cancer 1993; 71: 3873–81.
26. Woodruff K, Wang N, May W et al. The clonal nature of mediastinal germ cell tumors and acute myelogenous leukemia. A case report and review of the literature. Cancer Genet Cytogenet 1995; 79: 25–31.
27. Orazi A, Neiman RS, Ulbright TM et al. Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors. Cancer 1993; 71: 3873–81.
28. Geurts van Kessel A, Van Drunen E, De Jong B et al. Chromosome 12q heterozygosity is retained in i(12p)-positive testicular germ cell tumor cells. Cancer Genet Cytogenet 1989; 40: 129–34.
29. Irie J, Kawai K, Ueno Y et al. Malignant germ cell tumor of the anterior mediastinum with leukemia-like infiltration. Acta Pathol Jpn 1985; 1561–70.
30. Goedert JJ, Cote TR, Virgo P et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998; 351: 1833–9.
31. Sung M-T, MacLennan GT, Lopez-Beltran A et al. Primary mediastinal seminoma. Am J Surg Pathol 2008; 32: 146–55.
32. Hentrich MU, Black NG, Schmid P et al. Testicular germ cell tumors in patients with human immunodeficiency virus Infection. Cancer 1996; 77: 2109–17.
33. Timmerman JM, Northfelt DW, Small EJ. Malignant germ cell tumors in men infected with the human immunodeficiency virus: natural history and results of therapy. J Clin Oncol 1995; 13: 1391–7.
34. Тюляндин С.А. Лечение диссеминированных герминогенных опухолей у мужчин. Дис. ... докт. мед. наук, 1993.
35. Hentrich MU, Brack NG, Schmid P et al. Testicular germ cell tumors in patients with human immunodeficiency virus infection. Cancer 1996; 77: 109–16.
36. Nichols CR, Loehrer PJ, Einhorn LH et al. Phase III study of cisplatin, etoposide and bleomycin or etoposide, ifosfamide and cisplatin in advanced stage germ cell tumors: An intergroup trial. Proc Am Soc Clin Oncol 1995; 14: 239.
37. Albers P, Weinknecht S, Krege S et al. Prediction of necrosis after chemotherapy of advanced germ cell tumors – results of a prospective multicenter trial of the GTCSG. J Urol 2002; 167: 172.
38. De Santis M, Bokemeyer C, Becherer A et al. Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) for residual postchemotherapy masses in patients with bulky seminoma. J Clin Oncol 2001; 19: 3740–4.
39. Aprikian AG, Herr HW, Bajorin DF et al. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular non-seminomatous germ cell tumors. Cancer 1994; 74: 1329–34.
40. Hartmann JT, Candelaria M, Kuczyk MA et al. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumors. Eur J Cancer 1997; 33: 843–7.
41. Fizazi K, Tjulandin S, Salvioni R et al. Viable malignant cells after primary chemotherapy for disseminated non-seminatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy results from an international study. J Clin Oncol 2001; 19: 2647–57.
Авторы
А.В.Пивник1, Н.В.Серегин2, Ю.Г.Пархоменко3, О.А.Тишкевич3, А.М.Ковригина4, Б.М.Груздев5, Е.В.Петрова5, Е.Б.Ликунов6
1 Национальный медико-хирургический центр им. Н.И.Пирогова, Москва;
2 Городская клиническая больница №60, Москва
3 Клиническая инфекционная больница №2, Москва
4 Российский онкологический центр РАМН, Москва
5 Московский городской центр СПИД,
6 ФНКЦ ДГОИ Росздрава, Москва
1 Национальный медико-хирургический центр им. Н.И.Пирогова, Москва;
2 Городская клиническая больница №60, Москва
3 Клиническая инфекционная больница №2, Москва
4 Российский онкологический центр РАМН, Москва
5 Московский городской центр СПИД,
6 ФНКЦ ДГОИ Росздрава, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.